Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.71 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873387 | 1.00 | CSNK1E (0.71) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| SCHEMBL10399079 | 1.00 | CSNK1E (0.71) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| SCHEMBL8161936 | 1.00 | CSNK1E (0.71) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| SCHEMBL8420654 | 1.00 | CSNK1E (0.71) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| SCHEMBL11455433 | 1.00 | CSNK1E (0.71) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| SCHEMBL4878177 | 1.00 | CSNK1E (0.71) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| Water SCHEMBL6256326 | 0.98 | CSNK1E (0.69) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| Hydrochloric Acid SCHEMBL10939849 | 0.98 | CSNK1E (0.69) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| Bromide SCHEMBL14128593 | 0.98 | CSNK1E (0.69) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 | |
| Hydrochloric Acid SCHEMBL1072928 | 0.98 | CSNK1E (0.69) | CSNK1EEPHX1SIGMAR1ANPEPSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11254685-B2 | Abuse-resistant long-acting release opioid prodrugs | SUZHOU RUNXINDATAI PHARMACEUTICS LTD CO. (CN) | 2022-02-22 | — | — | US | disclosed |
| US-20200148694-A1 | ABUSE-RESISTANT LONG-ACTING RELEASE OPIOID PRODRUGS | SUZHOU RUNXINDATAI PHARMACEUTICS LTD CO. (CN) | 2020-05-14 | — | — | US | disclosed |
| EP-2318126-A2 | WATER PURIFICATION MEMBRANES WITH IMPROVED FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010006196-A2 | WATER PURIFICATION MEMBRANES WITH IMPROVED FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254685-B2 | Abuse-resistant long-acting release opioid prodrugs | OPRK1, OPRM1, OPRL1 | CSNK1E 1863/4885EPHX1 1688/4885SIGMAR1 6/4885 |
| US-20200148694-A1 | ABUSE-RESISTANT LONG-ACTING RELEASE OPIOID PRODRUGS | OPRK1, OPRM1, OPRL1 | CSNK1E 1863/4885EPHX1 1688/4885SIGMAR1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.